Planned Parenthood / Dow Jones & Company Inc. / Bioceptive Inc. / Manufacturer A.H. Robins Co. / Congress of Obstetricians and Gynecologists / New England Journal / Bayer AG / Teva Women's Health Inc. / Teva Pharmaceutical Industries Ltd. / Bayer HealthCare Pharmaceuticals / /
Country
United States / /
Currency
USD / /
Event
Product Issues / Bankruptcy / /
Facility
Guttmacher Institute / Tulane University / University of New Mexico / /
IndustryTerm
trade / intrauterine device / employer-provided insurance / prong-like tool / copyright law / few separate medical devices / pharmaceutical / birth-control device / implantation device / /
American Congress / Tulane University / Flora Hewlett Foundation / U.S. Food and Drug Administration / University of New Mexico / National Women's Law Center / Guttmacher Institute / /
Person
Lauren Barry / Deborah Nucatola / Ben Cappiello / ANGELA CHEN / Marcy Funk / Saul Polamo As / Eve Espey / Mara Gandal-Powers / / /
Position
professor of gynecology / paralegal / senior director of medical services / legal counsel / spokeswoman / chief scientific officer / /
Product
Skyla / the first new intrauterine device / Mirena / NuvaRing / Dalkon Shield / Skyla / /
HEALTH & WELLNESS A Birth-Control Comeback: The IUD A Device More Effective Than Birth-Control Pills Seeks a New Market By ANGELA CHEN Dec. 16, 2013 7:06 p.m. ET